Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No problem. I do it for you guys...lol.
And in Washington State...article from this morning...
http://blog.seattlepi.com/seattlepolitics/archives/190759.asp?from=blog_last3
Washington Post article from early this morning...
Oregon applying for Medical Marijuana Dispensaries
http://www.washingtonpost.com/wp-dyn/content/article/2010/01/12/AR2010011200409.html
yup...front page of the New York Times...
Anyone else get this e-mail? http://us1.campaign-archive.com/?u=26602c29e5fe2eaa49b430c32&id=88139fa1c7&e=ad8228bdce
Anyone else get this e-mail? http://us1.campaign-archive.com/?u=26602c29e5fe2eaa49b430c32&id=88139fa1c7&e=ad8228bdce
CEO stated…
“We expect to have definitive agreements signed in the near future."
Do I need to spell it out for you? :)
01/11/2010 Cannabis Science Moving Towards Contracts & Licensing Agreements
Cannabis Science Outlines Objectives For The New Year; Highlights Include Moving Towards Contracts & Licensing Agreements For...
Date : 01/11/2010 @ 3:24PM
Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to announce Cannabis Science is in negotiations with several companies in the US and internationally to contract or license its formulations for development, certain rights to manufacturing processes, and the sale in each prospective jurisdiction and or country
Cannabis Science President & CEO, Dr. Robert Melamede, stated, "We are able to greatly accelerate our company's progress in the New Year by working with others doing research and sales for our cannabinoid medicines by entering into licensing agreements with them. We expect to have definitive agreements signed in the near future." Richard Cowan, Cannabis Science Inc.'s CFO said, "The fact that other groups are willing to enter into licensing agreements with us is further evidence of their respect for Dr. Melamede and his standing in the scientific community Dr. Melamede, is the retired Chairman of the Biology Department at the University of Colorado at Colorado Springs, where he also continues to teach." On January 25th as a part of its FDA Drug and new retail drug release initiatives the Company will be updating its new website to encompass the progress of each of its formulations to be released to the public through the FDA and other regulatory bodies. As well, the Company will be putting confidential patient surveys on its website. These confidential surveys are designed to produce information regarding how patients use cannabis for various medical conditions
Dr. Robert Melamede, Cannabis Science President and CEO, explained, "These surveys are an example of what we mean when we Cannabis Science Inc. is truly a patient-oriented company. We have their trust because we are patients ourselves. By working with patients both in person and online, we can further develop our knowledge base and add staff and consultants where they are needed." About Cannabis Science, Inc
Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance
Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as “anticipate,” “seek,” intend,” “believe,” “plan,” “estimate,” “expect,” "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements
yes I still need to add in some News Links and a few other bells and whistles. If anyone has anything they feel should be submitted to the iBox, please PM me.
CBIS $.33 + 10% NICE NEWS...
http://ih.advfn.com/p.php?pid=nmona&cb=1263241890&article=41058239&symbol=NB%5ECBIS
Good to see the $.30 resistance on bid now...should act as a support level from here on out...
Cannabis Science Outlines Objectives For The New Year; Highlights Include Moving Towards Contracts and Licensing Agreements For Research and Development of New MedicinesLast update: 1/11/2010 3:24:00 PMCOLORADA SPRINGS, Colo., Jan 11, 2010 (BUSINESS WIRE) -- Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to announce Cannabis Science is in negotiations with several companies in the US and internationally to contract or license its formulations for development, certain rights to manufacturing processes, and the sale in each prospective jurisdiction and or country. Cannabis Science President & CEO, Dr. Robert Melamede, stated, "We are able to greatly accelerate our company's progress in the New Year by working with others doing research and sales for our cannabinoid medicines by entering into licensing agreements with them. We expect to have definitive agreements signed in the near future." Richard Cowan, Cannabis Science Inc.'s CFO said, "The fact that other groups are willing to enter into licensing agreements with us is further evidence of their respect for Dr. Melamede and his standing in the scientific community Dr. Melamede, is the retired Chairman of the Biology Department at the University of Colorado at Colorado Springs, where he also continues to teach." On January 25th as a part of its FDA Drug and new retail drug release initiatives the Company will be updating its new website to encompass the progress of each of its formulations to be released to the public through the FDA and other regulatory bodies. As well, the Company will be putting confidential patient surveys on its website. These confidential surveys are designed to produce information regarding how patients use cannabis for various medical conditions. Dr. Robert Melamede, Cannabis Science President and CEO, explained, "These surveys are an example of what we mean when we Cannabis Science Inc. is truly a patient-oriented company. We have their trust because we are patients ourselves. By working with patients both in person and online, we can further develop our knowledge base and add staff and consultants where they are needed." About Cannabis Science, Inc. Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. Forward Looking Statements; This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements. SOURCE: Cannabis Science Inc.
Cannabis Science Inc. Dr. Robert J. Melamede, 1-888-889-0888 President & CEO
CBIS volume breaking out should be fun while we blow through resistance
iBox almost finished
CBIS $.30's almost gone only one MM left before uptick
$.30's getting hammered...gotta break soon in my opinion
I agree. A break of $.30 resistance would get us moving nicely in my opinion.
Positive news could send this stock flying.
Will be updating the iBox today...
Looking for continued upward movement here today.
Gonna be fun next week...everyone have a great weekend!
That bid at $.28 is solid...$.27's look just as good...limited downside from this level
too funny...whoever decided to whack at the close will be chasing this next week
CBIS I agree next week should be fun
It's been a while since they put out some news so I imagine we'll be hearing something from the company pretty soon
I think that they also ran into a few legal issues which spooked some investors as well...but they have since been resolved to my understanding.
I believe it was the result of an investor awareness campaign...and they apparently did a good job because the stock price moved from $.07 to $1.44 in 8 days. I've been hearing some rumors that the same group has been hired on for next week...so I would imagine you would want to be in before the herd as you can make money trading these types of plays
I just received the best confirmation that I could receive on this stock. Next week is going to be FUN.
CBIS...those who get in before Monday will be pleased in my opinion.
CBIS $.32's up
CBIS @ $.31 very thin to $.50
Not much left @ $.31 in my opinion, consider it a gift
CBIS $.31's about to go! We've crossed that middle bolly...next stop $.36
CBIS waking up $.31's getting hammered
CBIS starting to wake up
next thing you know...PSC will be on CBIS
$CBIS $.28 x $.30...HDSN soaking up the bid whacker